As of 2024-12-12, the Intrinsic Value of Hollister Biosciences Inc (HOLL.CN) is
0.20 CAD. This HOLL.CN valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y).
With the current market price of 0.15 CAD, the upside of Hollister Biosciences Inc is
35.70%.
The range of the Intrinsic Value is 0.15 - 0.25 CAD
HOLL.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(0.10) - (0.05) |
(0.06) |
-141.7% |
| DCF (Growth 10y) |
(0.04) - (0.08) |
(0.05) |
-135.1% |
| DCF (EBITDA 5y) |
0.15 - 0.25 |
0.20 |
35.7% |
| DCF (EBITDA 10y) |
0.19 - 0.37 |
0.27 |
86.4% |
| Fair Value |
0.08 - 0.08 |
0.08 |
-41.92% |
| P/E |
0.01 - 0.03 |
0.01 |
-95.7% |
| EV/EBITDA |
0.99 - 1.94 |
1.42 |
880.6% |
| EPV |
(0.23) - (0.34) |
(0.28) |
-294.3% |
| DDM - Stable |
0.11 - 0.34 |
0.22 |
53.8% |
| DDM - Multi |
(0.03) - (0.06) |
(0.04) |
-124.7% |
HOLL.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
39.13 |
| Beta |
0.97 |
| Outstanding shares (mil) |
269.88 |
| Enterprise Value (mil) |
35.14 |
| Market risk premium |
4.74% |
| Cost of Equity |
8.39% |
| Cost of Debt |
4.25% |
| WACC |
7.73% |